Press Releases


Latest News


Adamas Pharmaceuticals Issued Six Additional U.S. Patents
Dec 2, 2014 | General Releases

Adamas Pharmaceuticals to Present at Piper Jaffray Healthcare Conference
Nov 18, 2014 | General Releases

Adamas Pharmaceuticals to Present at 2014 Credit Suisse Healthcare Conference
Nov 5, 2014 | General Releases

Adamas Reports Third Quarter 2014 Financial Results
Nov 4, 2014 | Financial Releases

Adamas Pharmaceuticals Expands Its Phase 3 Program With ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Patients With Parkinson's Disease
Oct 28, 2014 | General Releases

Adamas Pharmaceuticals Announces Management Changes
Aug 13, 2014 | General Releases

Adamas Reports Second Quarter 2014 Financial Results
Aug 7, 2014 | Financial Releases

United States Patent Issued to Adamas Pharmaceuticals
Aug 5, 2014 | General Releases

Adamas Pharmaceuticals To Present At JMP Securities Healthcare Conference 2014
Jun 16, 2014 | General Releases

Adamas Pharmaceuticals Announces Rater Training Data on ADS-5102 for Parkinson's Disease Patients with Levodopa-Induced Dyskinesia
Jun 10, 2014 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10